These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9556127)

  • 1. Glutamate receptors are expressed by bone cells and are involved in bone resorption.
    Chenu C; Serre CM; Raynal C; Burt-Pichat B; Delmas PD
    Bone; 1998 Apr; 22(4):295-9. PubMed ID: 9556127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanical loading modulates glutamate receptor subunit expression in bone.
    Szczesniak AM; Gilbert RW; Mukhida M; Anderson GI
    Bone; 2005 Jul; 37(1):63-73. PubMed ID: 15922681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate does not play a major role in controlling bone growth.
    Gray C; Marie H; Arora M; Tanaka K; Boyde A; Jones S; Attwell D
    J Bone Miner Res; 2001 Apr; 16(4):742-9. PubMed ID: 11316002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation.
    Peet NM; Grabowski PS; Laketic-Ljubojevic I; Skerry TM
    FASEB J; 1999 Dec; 13(15):2179-85. PubMed ID: 10593865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific antagonists of NMDA receptors prevent osteoclast sealing zone formation required for bone resorption.
    Itzstein C; Espinosa L; Delmas PD; Chenu C
    Biochem Biophys Res Commun; 2000 Feb; 268(1):201-9. PubMed ID: 10652236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate.
    Lin TH; Yang RS; Tang CH; Wu MY; Fu WM
    Eur J Pharmacol; 2008 Jul; 589(1-3):37-44. PubMed ID: 18538763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NMDA type glutamate receptors expressed by primary rat osteoblasts have the same electrophysiological characteristics as neuronal receptors.
    Gu Y; Genever PG; Skerry TM; Publicover SJ
    Calcif Tissue Int; 2002 Mar; 70(3):194-203. PubMed ID: 11907717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active NMDA glutamate receptors are expressed by mammalian osteoclasts.
    Espinosa L; Itzstein C; Cheynel H; Delmas PD; Chenu C
    J Physiol; 1999 Jul; 518(Pt 1):47-53. PubMed ID: 10373688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
    Merle B; Itzstein C; Delmas PD; Chenu C
    J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
    Mentaverri R; Kamel S; Wattel A; Prouillet C; Sevenet N; Petit JP; Tordjmann T; Brazier M
    J Cell Biochem; 2003 Apr; 88(6):1145-56. PubMed ID: 12647297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functional glutamate signaling in bone].
    Hinoi E
    Yakugaku Zasshi; 2010 Sep; 130(9):1175-9. PubMed ID: 20823674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of evidence is not evidence of absence. Redundancy blocks determination of cause and effect.
    Chenu C; Itzstein C; Espinosa L
    J Bone Miner Res; 2001 Sep; 16(9):1728-9; author reply 1731-2. PubMed ID: 11547845
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of an N-methyl-D-aspartate-type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone.
    Patton AJ; Genever PG; Birch MA; Suva LJ; Skerry TM
    Bone; 1998 Jun; 22(6):645-9. PubMed ID: 9626403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of ionotropic glutamate receptors in human lymphocytes.
    Lombardi G; Dianzani C; Miglio G; Canonico PL; Fantozzi R
    Br J Pharmacol; 2001 Jul; 133(6):936-44. PubMed ID: 11454668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium influx via ionotropic glutamate receptors causes long lasting inhibition of metabotropic glutamate receptor-coupled phosphoinositide hydrolysis.
    Facchinetti F; Hack NJ; Balázs R
    Neurochem Int; 1998 Sep; 33(3):263-70. PubMed ID: 9759922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells.
    Sparapani M; Dall'Olio R; Gandolfi O; Ciani E; Contestabile A
    Exp Neurol; 1997 Nov; 148(1):157-66. PubMed ID: 9398458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
    Foster AC; Wong EH
    Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evidence for multiple forms of an N-methyl-D-aspartate recognition domain in rat brain using membrane binding techniques.
    Zuo P; Ogita K; Suzuki T; Han D; Yoneda Y
    J Neurochem; 1993 Nov; 61(5):1865-73. PubMed ID: 7901335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamatergic regulation of bone remodeling.
    Chenu C
    J Musculoskelet Neuronal Interact; 2002 Mar; 2(3):282-4. PubMed ID: 15758455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.